Clonidine as Adjunct Therapy for the Treatment of Neonatal Abstinence Syndrome
NCT00510016
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
80
Enrollment
NIH
Sponsor class
Conditions
Neonatal Abstinence Syndrome
Interventions
DRUG:
Clonidine HCL
Sponsor
National Institute on Drug Abuse (NIDA)
Collaborators
[object Object]